DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Nauck MA, Meininger G, Sheng D. et al.
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: A randomized, double-blind, non-inferiority trial.
Diabetes Obes Metab 2007;
9: 194-205
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.